Relapsing Multiple Sclerosis Study

Now Enrolling in Raleigh and Savannah

● Now Enrolling

About this research study

With no definite cause established, MS has been hypothesized to result from a complex interaction between individual genetic susceptibility and environmental factors that act as triggers.

Approximately 85% of patients with MS initially have a relapsing form of MS (RMS), which is characterized by alternating periodic acute exacerbations of disease activity (relapses) and periods of remission, consisting of partial or complete recovery. If you suffer from RMS, sign up to learn more about a study seeking to compare an investigational RMS medication to an approved RMS medication. This study will include up to 14 clinic visits with the option of an additional 13 visits for eligible participants interested in the extension study.

Eligible participants...

Must be age 18 to 55 and be diagnosed with relapsing multiple sclerosis
Must have at least 1 of the following:
- 1 or more documented relapses within the past year
- 2 or more documented relapses within the past 2 years
- 1 or more documented Gd-enhancing lesions on an MRI scan within the past year
Will receive compensation for study-related time
Do not need insurance to join this study

For more information, complete the form on this page. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. There is no obligation to participate — you can decide if the study is right for you.

More information about participating in a clinical trial...

After you submit your information, a Velocity enrollment specialist will contact you.

Participating in a study is an important decision — we’re here to help you before, during, and after studies.

Please note: Health insurance is NOT required to join.

Is participation voluntary after I submit my information?

Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, the participant’s role in the study, potential side effects, the number of visits that may be required, and more. Participants must sign an informed consent form to join the study.

Will I receive compensation?

While participation in a clinical study is voluntary, you may be paid for study-related time. After you submit your information, a Velocity enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible payment with you.

Enter your info

Company

This field is for validation purposes and should be left unchanged.

Name(Required)

Phone(Required)

Date of birth(Required)

Age can help us determine study eligibility (you must be age 18 or older to submit this form).

Month

Day

Year

Location and study of interest(Required)

Gender

Preferred language

Are you Hispanic or Latino?(Required)

Race(Required)

Select one or more designations that best describe you. This information can help Velocity better ensure all populations are represented in research.

American Indian or Alaskan Native

Asian

Black or African American

Native Hawaiian or Other Pacific Islander

White or Caucasian

This field is hidden when viewing the form

MobileOptIn

By entering your email address and/or phone number on this form, you represent that you are at least 18 years of age and you consent to receiving telephone calls and/or emails from Velocity Clinical Research or a third party on behalf of Velocity Clinical Research. For any help regarding messaging, please email us at [email protected]. For full details, refer to Velocity's privacy policy and website terms of use. Submissions on this website are not monitored 24/7. Do NOT submit personal health or medical information on this form. If you are enrolled in a trial and have questions, please call your research site.

Study Locations

Raleigh, North Carolina • Velocity Clinical Research at Raleigh Neurology

1520 Sunday Drive, Suite 315, Raleigh, NC 27607
Phone: (984) 251-1336